You check your blood work every 8 to 12 weeks. You look for red flags: creatinine above 1.3, ALT above 60, HDL below 30. But by the time a single marker has crossed into the danger zone, the underlying process has been running for weeks. The real skill is not recognizing outliers: it is recognizing the pattern that produces them.
Across the physiology of AAS use, five lab patterns stand out as reliable predictors of trouble before any symptoms show up. Each pattern is a combination of markers, and taken together they tell a story that no single value can tell alone.
The Rising Hematocrit + Falling Ferritin Duet
Hematocrit climbs week by week, heading toward 52-54%, while ferritin keeps dropping: below 40, then below 30, then below 20. That pattern is a red flag. It predicts phlebotomy-induced iron deficiency 4 to 6 weeks before ferritin actually hits critical levels.
What is happening: AAS stimulate erythropoiesis. Your bone marrow produces more red blood cells, which consumes iron. If you are also donating blood to manage HCT, each donation removes 200-250 mg of iron. The combination of increased production and active depletion creates a ferritin drain that accelerates over time.
Action: When HCT is trending up and ferritin is below 50, start monitoring ferritin monthly. When ferritin hits 30, hold blood donations and begin oral iron supplementation (iron bisglycinate, 25-50 mg/day). Recheck ferritin in 6-8 weeks. Naringin and grapefruit extract can help modulate HCT without additional phlebotomy.
The 30–30 Rule
HCT + Ferritin Pattern
AST Higher Than ALT with Normal GGT
AST is 55, ALT is 35, GGT is 22. A standard lab report would flag elevated AST, ALT, or both. But the pattern — AST > ALT with normal GGT — tells a different story than the individual numbers suggest.
What is happening: AST is found in both the liver and skeletal muscle. ALT is more liver-specific. When AST is higher than ALT and GGT is normal, the source is almost certainly muscle, not liver. This is the classic "muscle leak" signature: training-related microtrauma releasing AST into the bloodstream.
Action: Check CK to confirm muscle origin (elevated CK confirms muscle leak). Check training status — were you adequately rested before the draw? If CK is elevated and training was recent, the pattern is benign. No need to stop orals, no need for liver workup. If AST remains > ALT with elevated GGT after proper rest (72 hours), then investigate liver origin.
The GGT Gate
AST > ALT + Normal GGT
Falling HDL + Rising Triglycerides
HDL is trending from 45 to 35 to 28 over consecutive draws. Triglycerides are moving from 100 to 150 to 190. Neither value is in the critical range individually, but the pattern, falling HDL with rising triglycerides, is the earliest metabolic red flag in AAS users.
What is happening: This combination signals developing atherogenic dyslipidemia and early insulin resistance. HDL drops from AAS pharmacology. Triglycerides rise from a combination of AAS-driven hepatic VLDL production and declining insulin sensitivity. Together, they indicate that your metabolic health is shifting in a direction that, if uncorrected, will produce a significantly atherogenic lipid profile.
Action: Compound audit: which compounds are contributing most to this pattern (trenbolone, Anadrol, and Winstrol are the worst offenders)? Add omega-3 fatty acids (3-4 g/day EPA+DHA). Check fasting glucose and HbA1c: if glucose is above 100 or HbA1c above 5.5%, metabolic intervention is needed. Dose reduction is a reasonable first step to try yourself; lipid medications are a prescription decision for a licensed medical professional.
This Pattern Predicts HbA1c Elevation
HDL Decline + TG Rise
eGFR Decline with Stable Cystatin C
Over 12 months, creatinine-based eGFR slides from 95 to 82 to 75. Cystatin C, though, stays locked at 0.85 mg/L, which corresponds to an eGFR of ~105. That contrast is the tell: the drop is a false alarm, driven by muscle mass and training, not kidney damage.
What is happening: Creatinine is a byproduct of muscle metabolism. More muscle mass = more creatinine production. AAS increase muscle mass, and training releases creatinine into the blood. The eGFR equation reads the resulting creatinine as "reduced kidney function" when the kidneys are actually working perfectly.
Action: If your eGFR has dropped below 85 and you are a muscular athlete (especially on AAS), order Cystatin C. A Cystatin C-based eGFR that is 10+ points higher confirms muscle artifact. Once confirmed, rely on Cystatin C for future monitoring and stop worrying about kidney damage unless Cystatin C also declines.
eGFR Decline + Stable Cystatin C
TSH Rising + Low T3
TSH creeps up, 2.5 then 3.2 then 3.8, while free T3 drops, 3.5 then 3.0 then 2.5 pg/mL. The standard response is to prescribe levothyroxine. But this pattern is often not thyroid disease. It's "low T3 syndrome," a hypothalamic adaptation to AAS and/or caloric restriction.
What is happening: AAS suppress TBG (thyroxine-binding globulin), which alters measured total T4 and T3. Caloric restriction (common in athletes) reduces peripheral conversion of T4 to active T3. The combination produces a low-T3 state that is not primary hypothyroidism but an adaptive response: the body is conserving energy by reducing active thyroid hormone.
Action: Check reverse T3 (rT3). If rT3 is elevated, the pattern is non-thyroidal illness (or AAS/calorie adaptation), not primary thyroid disease. Do not medicate with thyroid hormones: they will suppress TSH further and may worsen the underlying metabolic adaptation. Instead, address the root cause: caloric intake, training volume, and AAS compound choice.
The Reverse T3 Confirmation
TSH Rising + Low Free T3
Using Patterns for Proactive Monitoring
Pattern recognition is what flips blood work from retrospective to prospective. Instead of seeing what already went wrong, you see what's about to go wrong. Here's how to work pattern tracking into your monitoring:
- Track trends, not thresholds. A single marker out of range tells you something is wrong now. A marker trending in a concerning direction over 3-4 draws tells you what will be wrong in 8-12 weeks if nothing changes.
- Use a spreadsheet or tracking tool. Enter every blood draw into a tracking system that allows you to visualize trends. GearCheck's automated analysis does this automatically, but even a simple spreadsheet with conditional formatting catches patterns that raw lab reports hide.
- Set personal action thresholds. For each pattern, define what triggers action. Example: "If HDL drops 15% from baseline AND triglycerides rise 30% from baseline in consecutive draws, I will audit compounds and add omega-3." Concrete triggers prevent emotional decision-making.
- Confirm before acting. Patterns are strong signals, but they are not diagnoses. When a pattern triggers, confirm with additional markers (Cystatin C, rT3, CK, ApoB) before making significant changes to your cycle.
The five patterns above cover the most common early warning signals in AAS users. But the principle applies far beyond that list. Across every health marker you track, the pattern carries more weight than any single value. Train yourself to read patterns, not numbers.